Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Offers New Oral Option for Psoriasis
2
LEADderm Enters Third Year with Focus on Leadership, Values, and Reinvigoration
3
Smoking Associated with Increased Nail Psoriasis Severity, Case-Control Study Finds
4
Why Do Some Psoriasis Patients Respond Differently to Biologics? New Study Offers Clues
5